A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Condition: B-cell Non Hodgkin Lymphoma Interventions: Drug: Odronextamab; Drug: Loncastuximab tesirine; Drug: Rituximab; Drug: Ifosfamide; Drug: Carboplatin; Drug: Etoposide; Drug: Etoposide Phosphate; Drug: Dexamethasone; Biological: CAR T-cells (TBC) Sponsors: University of Birmingham; Cancer Research UK; Fight Kids Cancer; Regeneron Pharmaceuticals; ADC Therapeutics SA Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Dexamethasone | Lymphoma | Non-Hodgkin's Lymphoma | Pediatrics | Research | Rituxan | Study